P67-phox (NCF2) lacking exons 11 and 12 is functionally active and leads to an extremely late diagnosis of chronic granulomatous disease (CGD)

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • J. Roesler - (Author)
  • F. Segerer - , University Hospital of Würzburg (Author)
  • H. Morbach - , University Hospital of Würzburg (Author)
  • S. Kleinert - , University Hospital of Würzburg (Author)
  • S. Thieme - , Department of Paediatrics (Author)
  • A. Rösen-Wolff - , Department of Paediatrics (Author)
  • J.G. Liese - , University Hospital of Würzburg (Author)

Abstract

Two brothers in their fifties presented with a medical history of suspected fungal allergy, allergic bronchopulmonary aspergillosis, alveolitis, and invasive aspergillosis and pulmonary fistula, respectively. Eventually, after a delay of 50 years, chronic granulomatous disease (CGD) was diagnosed in the index patient. We found a new splice mutation in the NCF2 (p67-phox) gene, c.1000 + 2T → G, that led to several splice products one of which lacked exons 11 and 12. This deletion was in frame and allowed for remarkable residual NADPH oxidase activity as determined by transduction experiments using a retroviral vector. We conclude that p67-phox which lacks the 34 amino acids encoded by the two exons can still exert considerable functional activity. This activity can partially explain the long-term survival of the patients without adequate diagnosis and treatment, but could not prevent progressing lung damage.

Details

Original languageEnglish
Article numbere34296
Number of pages6
JournalPLoS ONE
Volume7
Issue number4
Publication statusPublished - 13 Apr 2012
Peer-reviewedYes

External IDs

Scopus 84859708074

Keywords